🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Neurofilament Light Chain

Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels NCT07353216n/a1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Ofatumumab A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS) NCT06780150n/a93 sites📍 Aachen📍 Amberg📍 Arnsdorf Hoffmann-La Roche · Tests: Ocrelizumab Developing New Ways to Detect Respiratory Impairment Early in ALS NCT07844590n/a1 site📍 Philadelphia Thomas Jefferson University The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3) NCT05885295n/a1 site📍 London Imperial College London · Tests: MRI brain, Blood tests, cognitive assessments ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS NCT06733922Phase 414 sites📍 Calgary📍 Calgary📍 Edmonton Novartis Pharmaceuticals · Tests: ETNATM-ProgMS Non-Invasive Brain Stimulation to Improve Language in Down Syndrome. NCT07044804NA1 site📍 Rome Floriana Costanzo · Tests: Active Group (Active Anodal tDCS to the left IFG or Cathodal tDCS to the left IFG), Sham Group Novel Targetable BIOmarkers in ANorexia NervosA NCT05885724n/a1 site📍 Basel University Hospital, Basel, Switzerland Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS) NCT05418010Phase 22 sites📍 London📍 London Queen Mary University of London · Tests: Tyruko Injectable Product, Placebo The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT) NCT04855396n/a11 sites📍 San Diego📍 West Palm Beach📍 Iowa City University of Michigan Analysis of NfL and GFAP in Different Dietary Patterns NCT07312994n/a1 site📍 Salzburg Salzburger Landeskliniken Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery NCT07474909NA1 site📍 Poznan Poznan University of Medical Sciences · Tests: iv dexamethasone, pn dexamethasone, 0.9%NaCl Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease NCT04946916NA2 sites📍 Bron📍 Bron Hôpital le Vinatier · Tests: blood sample taken Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis NCT06339190n/a2 sites📍 Box Hill📍 Wantirna Monash University · Tests: Venepuncture Multicenter ALS Imaging Study NCT06735014n/a3 sites📍 Gainesville📍 Evanston📍 Minneapolis University of Minnesota · Tests: Magnetic Resonance Imaging, Plasma neurofilament light chain (NfL) quantification Early Versus Delayed Start of Ocrevus Zunovo for Relapsing Multiple Sclerosis NCT07878923n/a1 site📍 Oklahoma City Oklahoma Medical Research Foundation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy